Laboratoire de Biologie tissulaire et Ingénierie Thérapeutique – UMR 5305
Therapeutic engineering
- Learning from Life
Tissue Biology
- The secret life of cells and matrices
Translational Research
- Innovative solutions, models and applications
LBTI
OUR RESEARCH GROUPS
NEWS
A new mechanism regulating wound healing revealed by the LBTI
3 groups of the LBTI worked together to understand how the BMP-1 metalloprotease can regulate cell adhesion and corneal wound healing through the cleavage of the matricellular protein thrombospondin-1. This work is just published in Science Signaling and has been selected to be featured on the journal cover.
Read More
LBTI starts the formulation of promising antiviral drugs against Covid-19 for pulmonary delivery
CovidNanoMed project: “Nanoformulations of current therapeutic drug candidates against SARS-CoV-2 for pulmonary delivery”. ANR Flash Covid-19 – PI: Bernard Verrier https://anr.fr/fr/actualites-de-lanr/details/news/flash-anr-covid-19 The team of B. Verrier, with the help of the group of R. Terreux for bioinformatics and a partnership with CEA and INRAE, have now started the identification of several promising antiviral candidates among
Read MoreNouvelles technologies de single-molecule FISH multiplex (RNAscope – ACD)
Jeudi 20 février: présentation des technologies de FISH-RNAscope par la société BioTechne, 3ème étage (pallier)
Read More
‘Results in Brief’ – PolyVac H2020
The results of the EU project PolyVac ‘Polysaccharide-based membrane for sublingual vaccination’ were released on CORDIS. They include the post-doc project of Sofia Caridade and research projects of C. Monge and B. Verrier. https://cordis.europa.eu/article/id/413256-progress-on-needle-free-vaccine-to-fight-hiv
Read More
